Positive News SentimentPositive NewsNASDAQ:ONMD OneMedNet (ONMD) Stock Price, News & Analysis $0.86 +0.03 (+3.62%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends About OneMedNet Stock (NASDAQ:ONMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OneMedNet alerts:Sign Up Key Stats Today's Range$0.77▼$0.8750-Day Range$0.58▼$1.0952-Week Range$0.42▼$9.57Volume56,442 shsAverage Volume3.00 million shsMarket Capitalization$26.97 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewOneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.Read More… top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… OneMedNet Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks21st Percentile Overall ScoreONMD MarketRank™: OneMedNet scored higher than 21% of companies evaluated by MarketBeat, and ranked 594th out of 675 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for OneMedNet.Read more about OneMedNet's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of OneMedNet is -4.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OneMedNet is -4.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.40% of the float of OneMedNet has been sold short.Short Interest Ratio / Days to CoverOneMedNet has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in OneMedNet has recently decreased by 0.67%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOneMedNet does not currently pay a dividend.Dividend GrowthOneMedNet does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.40% of the float of OneMedNet has been sold short.Short Interest Ratio / Days to CoverOneMedNet has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in OneMedNet has recently decreased by 0.67%, indicating that investor sentiment is improving. News and Social Media3.3 / 5News SentimentN/A News SentimentOneMedNet has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 1 news article for OneMedNet this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for ONMD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added OneMedNet to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, OneMedNet insiders have not sold or bought any company stock.Percentage Held by Insiders45.72% of the stock of OneMedNet is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.95% of the stock of OneMedNet is held by institutions.Read more about OneMedNet's insider trading history. Receive ONMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OneMedNet and its competitors with MarketBeat's FREE daily newsletter. Email Address ONMD Stock News HeadlinesOneMedNet (NASDAQ:ONMD) Stock, Earnings Estimates, EPS, And RevenueOctober 4, 2024 | benzinga.comOneMedNet Announces Board Member Transition to Drive Growth Post-IPOOctober 2, 2024 | globenewswire.comThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. October 31, 2024 | Porter & Company (Ad)OneMedNet Announces Additional $1.7 Million Private PlacementSeptember 26, 2024 | globenewswire.comOneMedNet Corporation: OneMedNet Announces Receipt of Nasdaq Notices Regarding Delayed Forms 10-QSeptember 14, 2024 | finanznachrichten.deOneMedNet appoints Bob Golden as new CFOSeptember 12, 2024 | investing.comOneMedNet Announces Receipt of Nasdaq Notices Regarding Delayed Forms 10-QSeptember 12, 2024 | globenewswire.comOneMedNet appoints new CFOSeptember 10, 2024 | globenewswire.comSee More Headlines ONMD Stock Analysis - Frequently Asked Questions How have ONMD shares performed this year? OneMedNet's stock was trading at $0.81 at the beginning of 2024. Since then, ONMD shares have increased by 6.2% and is now trading at $0.86. View the best growth stocks for 2024 here. How do I buy shares of OneMedNet? Shares of ONMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of OneMedNet own? Based on aggregate information from My MarketBeat watchlists, some other companies that OneMedNet investors own include NVIDIA (NVDA), Meta Platforms (META), Honeywell International (HON), QUALCOMM (QCOM), Intel (INTC), Workday (WDAY) and Advanced Micro Devices (AMD). Company Calendar Today10/31/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Commercial physical research Sub-IndustryBusiness Services Current SymbolNASDAQ:ONMD Previous SymbolNASDAQ:ONMD CUSIPN/A CIK1849380 Webwww.onemednet.com Phone011-44-20-3833-4000FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.02 million Price / Sales26.40 Cash FlowN/A Price / Cash FlowN/A Book Value($0.40) per share Price / Book-2.15Miscellaneous Outstanding Shares31,396,000Free Float17,042,000Market Cap$26.97 million OptionableN/A Beta0.69 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report This page (NASDAQ:ONMD) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OneMedNet Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OneMedNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.